Approvals Withdrawn for Ten Able Labs ANDAs
Approvals for Ten Able Labs ANDAs Withdrawn
At the request of the beleaguered Able Laboratories (Cranbury, NJ) the US Food and Drug Administration (Rockville, MD) has withdrawn 10 of the company’s abbreviated new drug approvals. The drugs were voluntarily recalled in May after an internal investigation turned up improper laboratory practices, including failure to ensure that all drug product distributed had the safety, identity, quality, and purity that they are represented to possess; and failure to reject drug products that failed to meet established standards and specifications.
According to FDA’s Aug. 29 Federal Register notice, the withdrawn drugs are diphenoxylate hydrochloride and atropine sulfate tablets USP, methylphenidate HCL tablets USP, prochlorperazine suppositories USP, acetaminophen and codeine phosphate, acetaminophen and codeine phosphate, clorazepate dipotassium tablets, clorazepate dipotassium tablets, clorazepate dipotassium tablets, propoxyphene napsylate and acetaminophen tablets, and methylphenidate HCL extended-release Tablets USP.
–George Koroneos
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Cooperating With Our Customers Across the US
May 13th 2025Highlighting the importance for our clients to prepurchase multi-year maintenance contracts, in order to avoid their machines breaking or stopping to work suddenly and unexpectedly, to minimize the risk of interrupted production and emergency maintenance costs.
